Celiac disease associated with type 1 diabetes mellitus

Endocrinology and Metabolism Clinics of North America

Volumn 33, Issue 1, 2004, Pages 197-214

  Rewers, Marian ^a   Liu, Edwin ^b   Simmons, Jill ^b   Redondo, Maria J ^a   Hoffenberg, Edward J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN;

CELIAC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; GLUTEN FREE DIET; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING;

AUTOANTIBODIES; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; GLUTEN; HUMANS; IMMUNOGLOBULIN A; TRANSGLUTAMINASES;

HORDEUM VULGARE SUBSP. VULGARE; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 1842579174     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2003.12.007     Document Type: Review

References (129)

1. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M., et al. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med. 191:2000;603-612.
2. *0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 178:1993;187-196.
3. Gjertsen H.A., Sollid L.M., Ek J., Thorsby E., Lundin K.E. T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol. 39:1994;567-574.
4. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., et al. Structural basis for gluten intolerance in Celiac sprue. Science. 297:2002;2275-2279.
5. Murray J.A., Van Dyke C.T., Plevak M., Dierkheising R., Zinsmeister A.R., Melton L. Trends in the incidence of celiac disease in a North American community, 1950-2001: dramatic increase after 1998. Gastroenterology. 122:2002;A182.
6. Walker-Smith J., Guandalini S., Schmitz J., Shmerling D., Visakorpi J. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 65:1990;909-911.
7. Catassi C., Cellier C., Cerf-Bensussan N., Ciclitira P.J., Collin P., Corazza G.R., et al. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 13:2001;1123-1128.
8. Moyana T.N., Xiang J. The impact of endoscopic technology on gastrointestinal pathology. Ann Clin Lab Sci. 29:1999;200-208.
9. Feighery C., Weir D.G., Whelan A., Willoughby R., Youngprapakorn S., Lynch S., et al. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate? Eur J Gastroenterol Hepatol. 10:1998;919-925.
10. Maki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 348:2003;2517-2524.
11. Hoffenberg E.J., MacKenzie T., Barriga K.J., Eisenbarth G.S., Bao F., Haas J.E., et al. A prospective study of the incidence of childhood celiac disease. J Pediatr. 143:2003;308-314.
12. Catassi C., Fabiani E., Ratsch I., Coppa G., Giorgi P., Pierdomenico R., et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 412:1996;29-35.
13. Korponay-Szabo I.R., Kovacs J.B., Czinner A., Goracz G., Vamos A., Szabo T. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr. 28:1999;26-30.
14. Johnston S.D., Watson R.G., McMillan S.A., McMaster D., Evans A. Preliminary results from follow-up of a large-scale population survey of antibodies to gliadin, reticulin and endomysium. Acta Paediatr Suppl. 412:1996;61-64.
15. Fasano A., Berti I., Gerarduzzi T., Not T., Colletti R.B., Drago S., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States - A large multicenter study. Arch Intern Med. 163:2003;286-292.
16. Ferguson A., Kingstone K. Coeliac disease and malignancies. Acta Paediatr Suppl. 412:1996;78-81.
17. Cottone M., Termini A., Oliva L., Magliocco A., Marrone C., Orlando A., et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci. 44:1999;2538-2541.
18. Corrao G., Corazza G.R., Bagnardi V., Brusco G., Ciacci C., Cottone M., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 358:2001;356-361.
19. Collin P., Reunala T., Pukkala E., Laippala P., Keyrilainen O., Pasternack A. Coeliac disease-associated disorders and survival. Gut. 35:1994;1215-1218.
20. Johnston S.D., Watson R.G., McMillan S.A., Sloan J., Love A.H. Coeliac disease detected by screening is not silent-simply unrecognized. QJM. 91:1998;853-860.
21. O'Connor T.M., Cronin C.C., Loane J.F., O'Meara N.M., Firth R.G., Shanahan F., et al. Type 1 diabetes mellitus, coeliac disease, and lymphoma: a report of four cases. Diabet Med. 16:1999;614-617.
22. Askling J., Linet M., Gridley G., Halstensen T.S., Ekstrom K., Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis. Gastroenterology. 123:2002;1428-1435.
23. Catassi C., Fabiani E., Corrao G., Barbato M., De Renzo A., Carella A.M., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 287:2002;1413-1419.
24. Green P.H.R., Fleischauer A.T., Bhagat G., Goyal R., Jabri B., Neugut A.I. Risk of malignancy in patients with celiac disease. Am J Med. 115:2003;191-195.
25. Howell W.M., Leung S.T., Jones D.B., Nakshabendi I., Hall M.A., Lanchbury J.S., et al. HLA-DRB -DQA, and -DQB polymorphism in celiac disease and enteropathy- associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol. 43:1995;29-37.
26. Hall M.A., Mazzilli M.C., Satz M.L., et al. Coeliac disease study. Tsuji K., Aizawa M., Sasazuki T. HLA 1991. 1992;722-729 Oxford University Press, Oxford (United Kingdom).
27. Rewers M., Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 39:1996;807-812.
28. *0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol. 40:1994;138-142.
29. *0501 allele are essential for the onset of DQw2-positive and DQw2-negative coeliac disease. Clin Exp Immunol. 91:1993;153-156.
30. Petronzelli F., Bonamico M., Ferrante P., Grillo R., Mora B., Mariani P., et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet. 61:(Pt 4):1997;307-317.
31. Djilali-Saiah I., Schmitz J., Harfouch-Hammoud E., Mougenot J.F., Bach J.F., Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut. 43:1998;187-189.
32. Zhong F., McCombs C.C., Olson J.M., Elston R.C., Stevens F.M., McCarthy C.F., et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet. 14:1996;329-333.
33. Redondo M.J., Eisenbarth G.S. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia. 45:2002;605-622.
34. Greco L., Corazza G., Babron M.C., Clot F., Fulchignoni-Lataud M.C., Percopo S., et al. Genome search in celiac disease. Am J Hum Genet. 62:1998;669-675.
35. Auricchio S., Follo D., De Ritis G., Giunta A., Marzorati D., Prampolini L., et al. Does breast feeding protect against the development of clinical symptoms of celiac disease in children? J Pediatr Gastroenterol Nutr. 2:1983;428-433.
36. Maki M., Kallonen K., Lahdeaho M.L., Visakorpi J.K. Changing pattern of childhood coeliac disease in Finland. Acta Paediatr Scand. 77:1988;408-412.
37. Ivarsson A., Persson L.A., Nystrom L., Hernell O. The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors. Eur J Epidemiol. 18:2003;677-684.
38. Howdle P.D., Blair Zajdel M.E., Smart C.J., Trejdosiewicz L.K., Blair G.E., Losowky M.S. Lack of a serologic response to an E1B protein of adenovirus 12 in coeliac disease. Scand J Gastroenterol. 24:1989;282-286.
39. Mahon J., Blair G.E., Wood G.M., Scott B.B., Losowsky M.S., Howdle P.D. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction. Gut. 32:1991;1114-1116.
40. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 120:2001;636-651.
41. Reunala T.L. Dermatitis herpetiformis. Clin Dermatol. 19:2001;728-736.
42. Hoffenberg E.J., Bao F., Eisenbarth G.S., Uhlhorn C., Haas J.E., Sokol R.J., et al. Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr. 137:2000;356-360.
43. Hoffenberg E.J., MacKenzie T., Barriga K.J., Eisenbarth G.S., Bao F., Erlich H., et al. Clinical features of screening-identified celiac disease in early childhood. Gastroenterology. 122:2002;A18.
44. Kemppainen T., Kroger H., Janatuinen E., Arnala I., Lamberg-Allardt C., Karkkainen M., et al. Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone. 25:1999;355-360.
45. Hadjivassiliou M., Grunewald R., Sharrack B., Sanders D., Lobo A., Williamson C., et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain. 126:2003;685-691.
46. Acerini C.L., Ahmed M.L., Ross K.M., Sullivan P.B., Bird G., Dunger D.B. Coeliac disease in children and adolescent with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med. 15:1998;38-44.
47. Fabiani E., Catassi C., Villari A., Gismondi P., Pierdomenico R., Ratsch I.M., et al. Dietary compliance in screening-detected coeliac disease adolescents. Acta Paediatr Suppl. 412:1996;65-67.
48. Mustalahti K., Collin P., Sievanen H., Salmi J., Maki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet. 354:1999;744-745.
49. Maki M., Holm K., Lipsanen V., Hallstrom O., Viander M., Collin P., et al. Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet. 338:1991;1350-1353.
50. Green P.H.R., Stavropoulos S.N., Panagi S.G., Goldstein S.L., Mcmahon D.J., Absan H., et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 96:2001;126-131.
51. Yahya K., Zipser R., Baisch D., Patel S., Monarch E. Changing patterns of physician diagnosis of adult celiac disease in the United States. [abstract] Gastroenterology. 122:2002;S1195.
52. Schuppan D., Hahn E.G. IgA anti-tissue transglutaminase: setting the stage for coeliac disease screening. Eur J Gastroenterol Hepatol. 13:2001;635-637.
53. Bao F., Yu L.P., Babu S., Wang T.B., Hoffenberg E.J., Rewers M., et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun. 13:1999;143-148.
54. Chorzelski T.P., Sulej J., Tchorzewska H., Jablonska S., Beutner E.H., Kumar V. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci. 420:1983;325-334.
55. Murray J.A., Herlein J., Mitros F., Goeken J.A. Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol. 7:2000;584-587.
56. RCPA Quality Assurance Program. Immunology newsletter April 2002;4(1):14-20. Available at: http://www.rcpaqap.com.au/immunology/newsapr2002. pdf. Accessed January 19, 2004.
57. Liu E., Bao F., Barriga K., Miao D., Yu L.P., Erlich H.A., et al. Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease. Clinical Gastroenterology and Hepatology. 1:2003;356-362.
58. Tursi A., Brandimarte G., Giorgetti G.M. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol. 36:2003;219-221.
59. Clark J.A., Callicoat P.A., Brenner N.A., Bradley C.A., Smith D.M. Selective Iga Deficiency in Blood-Donors. Am J Clin Pathol. 80:1983;210-213.
60. Collin P., Maki M., Keyrilainen O., Hallstrom O., Reunala T., Pasternack A. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol. 27:1992;367-371.
61. Cataldo F., Marino V., Bottaro G., Greco P., Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr. 131:1997;306-308.
62. Cataldo F., Marino V., Bottaro G., Greco P., Ventura A. Celiac disease and selective immunoglobulin A deficiency. J Pediatr. 131:1997;306-308.
63. Dickey W., McMillan S.A., Callender M.E. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol. 25:1997;328-329.
64. Ivarsson A., Persson L.A., Juto P., Peltonen M., Suhr O., Hernell O. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 245:1999;63-68.
65. Catassi C., Fabiani E., Ratsch I.M., Coppa G.V., Giorgi P.L., Pierdomenico R., et al. The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 412:1996;29-35.
66. Lock R.J., Unsworth D.J. Identifying immunoglobulin-A-deficient children and adults does not necessarily help the serologic diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 28:1999;81-83.
67. Bazzigaluppi E., Lampasona V., Barera G., Venerando A., Bianchi C., Chiumello G., et al. Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun. 12:1999;51-56.
68. Pocecco M., Ventura A. Coeliac disease and insulin-dependent diabetes mellitus: A causal association? Acta Paediatr. 84:1995;1432-1433.
69. Rewers M., Eisenbarth G., Tudor S., Uhlhorn C., Bao F., Erlich H., et al. Increased risk of celiac disease in relatives of IDDM patients. Diabetes. 46:(Suppl 1):1997;8A.
70. Barera G., Bonfanti R., Viscardi M., Bazzigaluppi E., Calori G., Meschi F., et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics. 109:2002;833-838.
71. Saukkonen T., Savilahti E., Reijonen H., Ilonen J., Tuomilehto-Wolf E., Akerblom H.K. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med. 13:1996;464-470.
72. Crone J., Rami B., Huber W.D., Granditsch G., Schober E. Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 37:2003;67-71.
73. Collin P., Kaukinen K., Valimaki M., Salmi J. Endocrinological disorders and celiac disease. Endocr Rev. 23:2002;464-483.
74. Westman E., Ambler G.R., Royle M., Peat J., Chan A. Children with coeliac disease and insulin dependent diabetes mellitus - growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab. 12:1999;433-442.
75. Amin R., Murphy N., Edge J., Ahmed M.L., Acerini C.L., Dunger D.B. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care. 25:2002;1117-1122.
76. Freemark M., Becker D., Litton J., Treem W. The effect of subclinical celiac disease on bone mineral density (BMD) in children with type 1 diabetes. Pediatr Res. 53:2003;130A.
77. Holmes G.K.T. Screening for coeliac disease in type 1 diabetes. Arch Dis Child. 87:2002;495-499.
78. Freemark M., Levitsky L.L. Screening for celiac disease in children with type 1 diabetes - two views of the controversy. Diabetes Care. 26:2003;1932-1939.
79. Iafusco D., Rea F., Prisco F. Hypoglycemia and reduction of the insulin requirement as a sign of celiac disease in children with IDDM. Diabetes Care. 21:1998;1379-1381.
80. Mohn A., Cerruto M., Iafusco D., Prisco F., Tumini S., Stoppoloni O., et al. Celiac disease in children and adolescents with type I diabetes: Importance of hypoglycemia. J Pediatr Gastroenterol Nutr. 32:2001;37-40.
81. Schober E., Bittmann B., Granditsch G., Huber W.D., Huppe A., Jager A., et al. Screening by anti-endomysium antibody for celiac disease in diabetic children and adolescents in Austria. J Pediatr Gastroenterol Nutr. 30:2000;391-396.
82. Saukkonen T., Vaisanen S., Akerblom H.K., Savilahti E. Coeliac disease in children and adolescents with type 1 diabetes: a study of growth, glycaemic control, and experiences of families. Acta Paediatr. 91:2002;297-302.
83. Calero P., RibesKoninckx C., Albiach V., Carles C., Ferrer J. IgA antigliadin antibodies as a screening method for nonovert celiac disease in children with insulin-dependent diabetes mellitus. J Pediatr Gastroenterol Nutr. 23:1996;29-33.
84. Lorini R., Scaramuzza A., Vitali L., dAnnunzio G., Avanzini M.A., DeGiacomo C., et al. Clinical aspects of coeliac disease in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 9:1996;101-111.
85. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology. 117:1999;297-303.
86. Toscano V., Conti F.G., Anastasi E., Mariani P., Tiberti C., Poggi M., et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol. 95:2000;1742-1748.
87. Norris J.M., Barriga K., Klingensmith G., Hoffman M., Eisenbarth G.S., Erlich H.A., et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 290:2003;1713-1720.
88. Ziegler A.G., Schmid S., Huber D., Hummel M., Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 290:2003;1721-1728.
89. Rewers M, Eisenbarth GS, Uhlhorn C, Bao F, Barriga K, Yu L, et al. Transglutaminase antibodies do not predict islet autoimmunity inchildren at high risk of diabetes. 4th Congress of the Immunology of Diabetes Society. Fiuggi, Italy, November 10-15, 1999.
90. Hummel M., Bonifacio E., Naserke H.E., Ziegler A.G. Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care. 25:2002;1111-1116.
91. Pastore M.R., Bazzigaluppi E., Belloni C., Arcovio C., Bonifacio E., Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab. 88:2003;162-165.
92. Anson O., Weizman Z., Zeevi N. Celiac disease: parental knowledge and attitudes of dietary compliance. Pediatrics. 85:1990;98-103.
93. Mayer M., Greco L., Troncone R., Auricchio S., Marsh M.N. Compliance of adolescents with coeliac disease with a gluten free diet. Gut. 32:1991;881-885.
94. Gemme G., Vignolo M., Naselli A., Garzia P. Linear growth and skeletal maturation in subjects with treated celiac disease. J Pediatr Gastroenterol Nutr. 29:1999;339-342.
95. Valdimarsson T., Lofman O., Toss G., Strom M. Reversal of osteopenia with diet in adult coeliac disease. Gut. 38:1996;322-327.
96. Holmes G.K., Prior P., Lane M.R., Pope D., Allan R.N. Malignancy in coeliac disease-effect of a gluten free diet. Gut. 30:1989;333-338.
97. Lerner A., Kumar V., Iancu T.C. Immunological diagnosis of childhood coeliac disease: comparison between antigliadin, antireticulin and antiendomysial antibodies. Clin Exp Immunol. 95:1994;78-82.
98. Fotoulaki M., Nousia-Arvanitakis S., Augoustidou-Savvopoulou P., Kanakoudi-Tsakalides F., Zaramboukas T., Vlachonikolis J. Clinical application of immunological markers as monitoring tests in celiac disease. Dig Dis Sci. 44:1999;2133-2138.
99. Hervonen K., Hakanen M., Kaukinen K., Collin P., Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol. 37:2002;51-55.
100. Bonamico M., Mariani P., Mazzilli M.C., Triglione P., Lionetti P., Ferrante P., et al. Frequency and clinical pattern of celiac disease among siblings of celiac children. J Pediatr Gastroenterol Nutr. 23:1996;159-163.
101. Farre M.A., Tlaskalova H., Nguyen H.H., Kocna P., Tuckova L., Krchnak V., et al. Interaction of natural and synthetic peptides derived from gliadin with different cell lines. Adv Exp Med Biol. 371B:1995;1371-1373.
102. Korponay-Szabo I., Kovacs J., Lorincz M., Torok E., Goracz G. Families with multiple cases of gluten-sensitive enteropathy. Z Gastroenterol. 36:1998;553-558.
103. De Vitis I., Ghirlanda G., Gasbarrini G. Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr Suppl. 412:1996;56-57.
104. Saukkonen T., Savilahti E., Reijonen H., Ilonen J., Tuomilehto-Wolf E., Akerblom H.K. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Childhood Diabetes in Finland Study Group. Diabet Med. 13:1996;464-470.
105. Talal A.H., Murray J.A., Goeken J.A., Sivitz W.I. Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol. 92:1997;1280-1284.
106. Cronin C.C., Feighery A., Ferriss B., Liddy C., Shanahan F., Feighery C. High prevalence of celiac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol. 92:1997;2210-2212.
107. Sjoberg K., Eriksson K.F., Bredberg A., Wassmuth R., Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med. 243:1998;133-140.
108. Fraser-Reynolds K.A., Butzner J.D., Stephure D.K., Trussell R.A., Scott R.B. Use of immunoglobulin A-antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes. Diabetes Care. 21:1998;1985-1989.
109. Carlsson A.K., Axelsson I.E., Borulf S.K., Bredberg A.C., Lindberg B.A., Sjoberg K.G., et al. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics. 103:1999;1248-1252.
110. Kordonouri O., Dieterich W., Schuppan D., Weber G., Muller C., Sarioglu N., et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med. 17:2000;441-444.
111. Gillett P.M., Gillett H.R., Israel D.M., Metzger D.L., Stewart L., Chanoine J.P., et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 15:2001;297-301.
112. Aktay A.N., Lee P.C., Kumar V., Parton E., Wyatt D.T., Werlin S.L. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr. 33:2001;462-465.
113. Hansen D., Bennedbaek F.N., Hansen L.K., Hoier-Madsen M., Hegedus L., Jacobsen B.B., et al. High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr. 90:2001;1238-1243.
114. Meloni G.F., Tomasi P.A., Bertoncelli A., Fanciulli G., Delitala G., Meloni T. Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia. J Endocrinol Invest. 24:2001;298-302.
115. Not T., Tommasini A., Tonini G., Buratti E., Pocecco M., Tortul C., et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia. 44:2001;151-155.
116. Spiekerkoetter U., Seissler J., Wendel U. General screening for celiac disease is advisable in children with type 1 diabetes. Horm Metab Res. 34:2002;192-195.
117. Hummel M., Bonifacio E., Stern M., Dittler J., Schimmel A., Ziegler A.G. Development of celiac disease-associated antibodies in offspring of parents with Type I diabetes. Diabetologia. 43:2000;1005-1011.
118. *02 allele. Diabetologia. 44:2001;1051-1053.
119. Williams A.J.K., Norcross A.J., Lock R.J., Unsworth D.J., Gale E.A.M., Bingley P.J. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care. 24:2001;504-509.
120. Collin P., Salmi J., Hallstrom O., Reunala T., Pasternack A. Autoimmune thyroid disorders and coeliac disease. Eur J Endocrinol. 130:1994;137-140.
121. Heneghan M.A., Stevens F.M., Cryan E.M., Warner R.H., McCarthy C.F. Celiac sprue and immunodeficiency states: a 25-year review. J Clin Gastroenterol. 25:1997;421-425.
122. Cataldo F., Marino V., Ventura A., Bottaro G., Corazza G.R. Prevalence and clinical features of selective immunoglobulin A deficiency in coeliac disease: an Italian multicentre study. Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP) and "Club del Tenue" Working Groups on Coeliac Disease. Gut. 42:1998;362-365.
123. George E., Mearin L., Bouquet J., Blomberg B.V., Stapel S., Elburg R.V., et al. High frequency of celiac disease in Down syndrome. J Pediatr. 128:1996;555-557.
124. Book L., Hart A., Black J., Feolo M., Zone J.J., Neuhausen S.L. Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet. 98:2001;70-74.
125. Carlsson A., Axelsson I., Borulf S., Bredburg A., Forslund M., Lindberg B., et al. Prevalence of IgA-antigliadin antibodies and IgA antiendomysium antibodies related to celiac disease in children with Down Syndrome. Pediatrics. 101:1998;272-275.
126. Bonamico M., Pasquino A.M., Mariani P., Danesi H.M., Culasso F., Mazzanti L., et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab. 87:2002;5495-5498.
127. Gillett P.M., Gillett H.R., Israel D.M., Metzger D.L., Stewart L., Chanoine J.P., et al. Increased prevalence of celiac disease in girls with Turner syndrome detected using antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol. 14:2000;915-918.
128. Ivarsson S.A., Carlsson A., Bredberg A., Alm J., Aronsson S., Gustafsson J., et al. Prevalence of coeliac disease in Turner syndrome. Acta Paediatr. 88:1999;933-936.
129. Iltanen S., Collin P., Korpela M., Holm K., Partanen J., Polvi A., et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome. Am J Gastroenterol. 94:1999;1042-1046.